China is going to reform how public money from different government ministries is allocated to the biotech industry through the creation of a top-level biotech leadership committee, to be launched by December 2004. Meanwhile, several government departments are drafting a national plan designed to provide direction to China's biotech sector in the next two decades. Critics say these measures, which are designed to better coordinate the nation's divergent endeavors in biotech and avoid duplication of efforts, will be effective only if the government introduces a better system to finance biotech research.
See more at Nature Biotechnology
